Sky Max Pharmatech Private Limited - Due diligence report

A 360° intelligence report on Sky Max Pharmatech Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2014-05-29 Patna, Bihar Active Unlisted Active Compliant
Share
SM Sky Max Pharmatech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sky Max Pharmatech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
65/100
Trust Score
Moderate

Sky Max Pharmatech Private Limited is assessed as Moderate with a Trust Score of 65/100. Sky Max Pharmatech Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Sky Max Pharmatech Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
65/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
DHARMENDRA KUMAR 01234567 Director 01/04/2018 6 yrs Approved
Arbind Kumar 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 45
Growth signals & trust indicators
Steady revenue growth: +1.42 over 1 year(s).
Latest year revenue grew 2.1x.
Operating for 12+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence63/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view55/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
16 Dec 2025
Director appointed
Arbind Kumar (Director)
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2023
Latest balance sheet
Filed with ROC
12 Feb 2021
Director ceased
KRISHNA MURARI HARI
Director ceased
RAM BRIND SINGH
29 May 2014
Incorporated
Registered with Roc Patna
Director appointed
DHARMENDRA KUMAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 1 financial year(s).
Net profit margin moved from 0.86 to 61%.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Wellhealth Clinics Private Limited U85100KL2018PTC052501 Kozhikode, Kerala, India
Santosh Handa Nursing Home Private Limited U85110UP1988PTC010321 Uttar Pradesh, Uttar Pradesh, India
Nrmd Physio Private Limited U85190MH2018PTC309946 Kandivali West, Maharashtra, India
Reeds Healthcare Private Limited U85100TN2016PTC104512 Chennai, Tamil Nadu, India
Zenvion Lifesciences U85100TZ2018PTC030539 Coimbatore, Tamil Nadu, India
Winpe Development Forum U85100DL2019NPL352984 Shahdara, Delhi, India
Raised Lines Foundation U85100DL2018NPL331136 New Delhi, Delhi, India
Neowomb Health Care Private Limited U85100AP2017PTC105665 Kakinada (Urban), Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sky Max Pharmatech Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sky Max Pharmatech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Sky Max Pharmatech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 65/100, distress signals and MSME payment-delay disclosures - know whether Sky Max Pharmatech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Sky Max Pharmatech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sky Max Pharmatech Private Limited an active company?

Sky Max Pharmatech Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Sky Max Pharmatech Private Limited financially healthy?

Sky Max Pharmatech Private Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Sky Max Pharmatech Private Limited?

Its overall Trust Score is 65/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sky Max Pharmatech Private Limited?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Sky Max Pharmatech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Sky Max Pharmatech Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Sky Max Pharmatech Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.